Akebia Therapeutics Inc. (AKBA)
NASDAQ · Healthcare
Akebia Therapeutics Inc. Operating Income 2014–2025
Akebia Therapeutics Inc. annual/quarterly operating income history and growth rate from 2014 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Akebia Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -4.7 M, a 134.75% decrease year-over-year.
- Akebia Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was 27.4 M, a 155.60% decrease year-over-year.
- Akebia Therapeutics Inc. annual operating income for 2025 was 23.5 M, a 146.56% decrease from 2024.
- Akebia Therapeutics Inc. annual operating income for 2024 was -50.5 M, a 9.11% increase from 2023.
- Akebia Therapeutics Inc. annual operating income for 2023 was -46.3 M, a 42.74% decrease from 2022.
- Akebia Therapeutics Inc. annual operating income for 2022 was -80.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Akebia Therapeutics Inc. Operating Income — FAQ
Akebia Therapeutics Inc. (AKBA) operating income over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is Akebia Therapeutics Inc.'s operating income?
Akebia Therapeutics Inc. (AKBA) reported operating income of $23M for fiscal 2025.
Where can I see AKBA's operating income history?
The chart and table above show Akebia Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.